US Patent 11761000 Compositions and their uses directed to huntingtin
Patent 11761000 was granted and assigned to Ionis Pharmaceuticals, Inc. on September, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 20 Sep, 2023
Golden AI
Edits made to:
Infobox (+13 properties)
Article (+585 characters)
US Patent 11761000 Compositions and their uses directed to huntingtin
Article
Patent abstract
Disclosed herein are compounds, compositions and methods for modulating the expression of huntingtin in a cell, tissue or animal. Further provided are methods of slowing or preventing Huntington's Disease (HD) progression using an antisense compound targeted to huntingtin. Additionally provided are methods of delaying or preventing the onset of Huntington's Disease (HD) in an individual susceptible to Huntington's Disease (HD). Also provided are uses of disclosed compounds and compositions in the manufacture of a medicament for treatment of diseases and disorders.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Susan M. Freier
Date of Patent
September 19, 2023
Patent Application Number
17352806
Date Filed
June 21, 2021
Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11761000 Compositions and their uses directed to huntingtin
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.